{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:40:57Z","timestamp":1783654857955,"version":"3.55.0"},"reference-count":32,"publisher":"Hogrefe Publishing Group","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vasa"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Summary: Background: Bridging Stent Grafts (BSG) are an essential element of fenestrated and branched endovascular aortic repair (FEVAR and BEVAR respectively). Until CE marking of a dedicated stent in late 2024, a variety of BSG were used. The aim of this study was to evaluate the outcomes of the iCover stent graft in this application. Patients and methods: We retrospectively analysed 22 consecutive patients treated at our institution with FEVAR and BEVAR between 05\/2023 and 09\/2024. The primary endpoint is a composite of target vessel (TV) technical success and freedom from target vessel instability (TVI) in the early and short-\/mid-term phase. Secondary endpoints consisted of early, short- and mid-term clinical outcomes. Results: Ninety-seven iCover stent grafts were used to bridge 90 target vessels: 23 for the coeliac arteries (CA), 23 for the superior mesenteric artery (SMA) and 50 for the renal arteries (RA); one iCover stent could not be implanted. The underlying aortic pathology was juxtarenal and pararenal aneurysm (12\/22; 54,5%), penetrating aortic ulcer (PAU) (2\/22; 9%), type Ia endoleak following infrarenal EVAR (3\/22; 13,6%), chronic type B aortic dissection with aneurysmal degeneration (1\/22; 4,5%), Safi type IV (3\/22; 13.6%) and Safi type V (1\/22; 4.5%) thoraco-abdominal aortic aneurysm (TAAA). The mean aneurysm diameter was 60,5 mm (+\/\u2013 10,6 mm). Four (18,2%) patients underwent urgent procedures. The median follow-up was 291,5 days (IQR 63-425,2). 3 patients (13,6%) died from non\u2013aneurysm-related causes. Assisted primary TV technical success was 98,88% (89\/90). One non-iCover related loss of TV was excluded from mid-term analysis. The TV patency was 98,88% (89\/90) in the early phase and 98,87% (88\/89) at mid-term follow-up. Cumulative freedom from TVI was 92,13% (82\/89). Conclusions: The iCover is effective and safe to use as a BSG in fenestrated endovascular aortic repair. Our results align with the available literature, but further studies are needed to validate iCover as BGS, especially in BEVAR.<\/jats:p>","DOI":"10.1024\/0301-1526\/a001239","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:17:10Z","timestamp":1759295830000},"page":"135-143","source":"Crossref","is-referenced-by-count":2,"title":["iCover as bridging stent graft in complex endovascular aortic repair"],"prefix":"10.1024","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3828-1680","authenticated-orcid":true,"given":"Oana","family":"Bartos","sequence":"first","affiliation":[{"name":"Department of Vascular Medicine, St. Josefs-Hospital, Wiesbaden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Reidt","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, St. Josefs-Hospital, Wiesbaden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Krassilnikov","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, St. Josefs-Hospital, Wiesbaden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Bachhuber","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, St. Josefs-Hospital, Wiesbaden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7076-9526","authenticated-orcid":true,"given":"Matthias","family":"Trenner","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, St. Josefs-Hospital, Wiesbaden, Germany"},{"name":"Vascular and Endovascular Surgery, Technical University of Munich, School of Medicine, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"101","reference":[{"key":"c1","doi-asserted-by":"publisher","DOI":"10.1177\/15266028221091894"},{"key":"c2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2018.01.023"},{"key":"c3","doi-asserted-by":"publisher","DOI":"10.1177\/1526602817752449"},{"key":"c4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.10.089"},{"key":"c5","doi-asserted-by":"publisher","DOI":"10.1177\/15266028211012403"},{"key":"c6","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2020.10.052"},{"key":"c7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.05.028"},{"key":"c8","doi-asserted-by":"publisher","DOI":"10.1177\/15266028221083458"},{"key":"c9","doi-asserted-by":"publisher","DOI":"10.1177\/15266028211016423"},{"key":"c10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2023.11.002"},{"key":"c11","unstructured":"Bentley InnoMed GmbH. Double win with bridging stents: FEVAR certifications for BeGraft and BeFlared; 2024. Available from:https:\/\/www.bentley.global\/newsitem\/60."},{"key":"c12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2025.01.029"},{"key":"c13","doi-asserted-by":"publisher","DOI":"10.1177\/15266028241289291"},{"key":"c14","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2024.04.006"},{"key":"c15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1188501"},{"key":"c16","first-page":"152660282513189","author":"\u00c1lvarez Marcos F","journal-title":"Journal of Endovascular Therapy"},{"key":"c17","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_543_18"},{"key":"c18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.06.011"},{"key":"c19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2023.06.037"},{"key":"c20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.07.079"},{"key":"c21","doi-asserted-by":"publisher","DOI":"10.1177\/15266028221083458"},{"key":"c22","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a001148"},{"key":"c23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.070334"},{"key":"c24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.12.036"},{"key":"c25","doi-asserted-by":"publisher","DOI":"10.1177\/15266028241270862"},{"key":"c26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2018.12.047"},{"key":"c27","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2016.04.004"},{"key":"c28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2015.12.046"},{"key":"c29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2021.05.029"},{"key":"c30","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a001081"},{"key":"c31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2017.11.005"},{"key":"c32","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2021.10.035"}],"container-title":["Vasa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/0301-1526\/a001239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:06:49Z","timestamp":1778933209000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/0301-1526\/a001239"}},"subtitle":["Mid-term analysis focusing on target vessel related outcomes"],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1024\/0301-1526\/a001239"],"URL":"https:\/\/doi.org\/10.1024\/0301-1526\/a001239","relation":{},"ISSN":["0301-1526","1664-2872"],"issn-type":[{"value":"0301-1526","type":"print"},{"value":"1664-2872","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}